SwedenBIO awards this prize annually to a life science company that has excelled during the year and has contributed to societal benefits that underline the importance of a successful life

This global prize aims to reward scientists at an early stage of their careers. The Science & SciLifeLab Prize for Young Scientists was established in 2013. Science, the American Association

In July EIT Health launched a new joint accelerator programme for Swedish start-ups in digital health and artificial intelligence with support from the Swedish Innovation Agency Vinnova within the framework

Deloitte recognizes BICO as the third fastest-growing company in Sweden in the annual Technology Fast 50 ranking. Deloitte’s annual ranking acknowledges the 50 fastest-growing technology companies based on revenue growth

In October 2021, Finnish startup Surgify’s bone cutting technology was taken into use on patients at Helsinki University Hospital. “The two surgical patients recovered well from their surgeries and returned

Novo Nordisk has entered into a definitive agreement to acquire Dicerna Pharmaceuticals (Dicerna) for a total equity value of approximately USD 3.3 billion. The acquisition of Dicerna’s ribonucleic acid interference

The new name and identity signifies a new phase of growth for the company and the agreement with US-based Regeneron is worth up to 900 million USD. The multi-target license

The purpose of the new programme is to rapidly identify technological solutions to the growing challenge of Alzheimer’s disease. Teams and researchers can apply now to be considered to take

Boehringer Ingelheim has ordered licenses from Qlucore at a value of approximately 142,000 EUR for the use of Qlucore Omics Explorer for two years. Boehringer Ingelheim is an existing Qlucore

Devyser Diagnostics has announced its intention to launch an initial public offering of its shares and to list its shares on Nasdaq First North Premier Growth Market. The offering is

I began to be interested in the problem of antibiotic resistance almost 30 years ago. A couple of colleagues and I were evaluating some patent applications describing the possibilities of

Danish research shows that people with COVID-19 who are hospitalized rarely have bacterial infections and antibiotics are therefore not needed at admission. About 95% of the people hospitalized with COVID-19

Norwegian start-up company AdjuTec’s novel antibiotic resistance breakers may help to facilitate reduced use of antibiotics. If there is one positive thing about the COVID-19 pandemic, it could perhaps be

Researchers at Karolinska Institutet, Umeå University, and the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic-resistant bacteria. Since the properties

Zipline, Pfizer and BioNTech has announced that Zipline has successfully completed the first long-range drone delivery of both authorized mRNA COVID-19 vaccines requiring ultra-cold-chain in Ghana. The collaboration of the

EMA’s human medicines committee (CHMP) has issued advice on the use of Merck’s (known as MSD outside the United States and Canada) Lagevrio (also known as molnupiravir or MK 4482)

Pfizer is seeking Emergency Use Authorization (EUA) of its investigational oral antiviral candidate, PAXLOVID, for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalizations or

Researchers at the University of Helsinki and the University of Eastern Finland first searched for suitable drug targets and repurposable drugs for treatment options for COVID-19. They found six candidate

Merck and Ridgeback’s Molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world. U.K.’s Medicines and Healthcare Products Regulatory Agency authorizes Molnupiravir for the treatment of mild-to-moderate COVID-19